NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Hepatitis Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hepatitis C Virus Immunology



New hepatitis C virus immunology research from University of Bari described



August 6th, 2007

Current study results from the report, "Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome," have been published. According to a study from Bari, Italy, "T cell-mediated protection against HCV depends on constantly activated effector CD8(+)T cells that control emergence, spread and expansion of the virus. Why these cells fail to contain HCV replication in 70-80% of the individuals who develop persistent viremia is not clear."

"Although many reviews have focused on HCV's ability to interfere with the process of antigen presentation by dendritic cells (DC), only few have discussed the...


Source: Hepatitis Weekly (2007-08-06)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login